Pacira BioSciences, Inc. PCRX

PCRX Company Overview

Pacira BioSciences, Inc. is a U.S.-based biopharmaceutical company focused on developing, manufacturing, and commercializing non-opioid pain management and regenerative health solutions. The company operates primarily within the pharmaceuticals and medical therapeutics industries, with an emphasis on addressing post-surgical pain and musculoskeletal conditions. Pacira’s business model centers on proprietary drug delivery technologies designed to provide long-acting therapeutic benefits while reducing reliance on opioids.

The company’s primary revenue drivers are its branded pharmaceutical products, most notably EXPAREL, a long-acting local anesthetic, and IOVERA°, a cryoanalgesia-based pain management treatment. Pacira serves hospitals, ambulatory surgical centers, orthopedic practices, and other healthcare providers, primarily in the United States. Founded in 2006, the company evolved from a development-stage biotechnology firm into a commercial-stage organization following the U.S. regulatory approval and commercialization of EXPAREL, which established its position in the non-opioid pain management market.